Clinical Trials Browser

Tablets × Clear all

NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

Phase NA Recruiting

Localized Prostate Cancer

NCT07372625 2026-03-12

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Phase 1 Recruiting

Other solid neoplasm

TP53 Y220C Mutation

NCT04802590 2026-03-04

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma, Mantle-Cell

NCT07217938 2026-03-03

TRADstat

Phase 2 Recruiting

Deglutition Disorders, Head and Neck Neoplasms

NCT07435584 2026-02-27

EVER-RECODE

Phase 1/2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04544995 2026-01-21

Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)

Phase 1 Terminated

47 enrolled 43 charts

Neoplasms, Neuroblastoma, Osteosarcoma

NCT07002177 2026-01-07

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

Phase 1/2 Recruiting

Breast Neoplasms

NCT07292207 2025-12-18

ARCHE

Phase 2 Not yet recruiting

Breast Neoplasms

NCT03043924 2025-12-11

MRI-PCOS

Phase NA Completed

Polycystic Ovary Syndrome

NCT03556228 2025-12-11

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Phase 1/2 Recruiting

GastrointestinalHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Adenoid Cystic, Esophageal Neoplasms, Head and Neck Neoplasms, Laryngeal Diseases, Lung Neoplasms, Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms, Salivary Gland Neoplasms, Tracheal Diseases, Small Cell Lung Carcinoma

NCT04456920 2025-12-02

BIO-PSY

Phase NA Completed

193 enrolled 19 charts

Breast Neoplasms

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Phase 2 Recruiting

Breast Neoplasms, Cardiotoxicity

NCT07025005 2025-11-04

VRd MM Fibrate

Phase 4 Recruiting

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT05392608 2025-09-17

SEQUEL-Breast

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

NCT06041204 2025-09-03

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Phase NA Recruiting

Infertility, Female, Polycystic Ovary Syndrome

NCT06033092 2025-08-28

TOLERANT

Phase 2 Active not recruiting

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT04055493 2025-08-26

ADAPTcycle

Phase 3 Active not recruiting

Breast Neoplasms

NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2/3 Recruiting

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT05722795 2025-07-09

I-CONIC

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07042711 2025-06-29

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

Phase NA Active not recruiting

Nasopharyngeal Neoplasms

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

Phase 2/3 Completed

Polycystic Ovary Syndrome, Weight Gain

NCT04789057 2025-05-08

Captain

Phase 4 Recruiting

Smoking, Pulmonary Disease, Chronic Obstructive

NCT03544905 2025-04-22

Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT05907057 2025-04-11

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05247268 2025-04-06

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Phase 2 Recruiting

Endometrial Neoplasms

NCT02852486 2025-03-30

EDI-PIO

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

Phase EARLY_PHASE1 Not yet recruiting

CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

NCT04717700 2025-03-18

SABLe

Phase 2 Active not recruiting

Multiple Myeloma

NCT04722575 2025-03-13

NEO-TIM

Phase 2 Active not recruiting

Melanoma

NCT06275919 2025-03-13

MIRAGE

Phase 2 Recruiting

Meningioma

NCT04503694 2025-03-05

REGINA

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT06774885 2025-01-14

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

Phase 3 Not yet recruiting

Breast Neoplasms, Hot Flashes

NCT04233034 2024-11-27

CLVer

Phase 3 Completed

113 enrolled 42 charts

Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT06643221 2024-10-16

Allo-X

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity

NCT04554459 2024-08-14

Pona-CELL

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05163106 2024-08-02

NEOLETRIB

Phase 2 Completed

Breast Neoplasms

NCT05265988 2024-07-31

MERIDIAN

Phase 2 Completed

Prostatic Neoplasms

NCT05568940 2024-05-30

eTAPE

Endometriosis, Leiomyoma

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT04810182 2024-02-08

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Glioblastoma

NCT06229067 2024-01-29

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05370807 2023-10-24

RegoMel

Phase 2 Unknown

Melanoma

NCT05951309 2023-07-19

Myoinositol Treatment and Asprosin Levels in PCOS

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome, Arachnodactyly

NCT05909293 2023-06-18

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04028986 2023-05-16

Esmya Versus Surgery Before IVF/ICSI

Active not recruiting

Infertility, Female, Leiomyoma, Pregnancy Complications, Uterine Neoplasms

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

Phase EARLY_PHASE1 Withdrawn

Insulin Resistance, Prostatic Neoplasms

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Phase 4 Completed

Breast Neoplasms

NCT05330377 2023-04-25

GM-CLAG in Relapsed/Refractory FLT3-mutated AML

Phase 1 Withdrawn

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Phase NA Withdrawn

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction